A polyclonal outbreak of bloodstream infections by Enterococcus faecium in patients with hematologic malignancies

American Journal of Infection Control

Volumn 45, Issue 3, 2017, Pages 260-266

  Alatorre Fernández, Pamela ^a   Mayoral Terán, Claudia ^b   Velázquez Acosta, Consuelo ^a   Franco Rodríguez, Cecilia ^c   Flores Moreno, Karen ^b   Cevallos, Miguel Ángel ^d   López Vidal, Yolanda ^b   Volkow Fernández, Patricia ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

^d INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

Author keywords

Molecular epidemiology; Mucosal barrier injury; Vancomycin resistant Enterococcus faecium

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; LINEZOLID; METHOTREXATE; METRONIDAZOLE; QUINOLONE DERIVATIVE; TEICOPLANIN; VANCOMYCIN; VINCRISTINE; BACTERIAL DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; FEMALE; GENE; GENETICS; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; LYMPHOMA; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS FAECIUM; VANCOMYCIN SENSITIVE ENTEROCOCCUS FAECIUM; ADOLESCENT; ADULT; CLASSIFICATION; COMPLICATION; EPIDEMIC; GENETIC VARIATION; GENOTYPE; GRAM POSITIVE INFECTION; HEMATOLOGIC DISEASE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; SEPSIS; SURVIVAL ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DISEASE OUTBREAKS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECIUM; FEMALE; GENETIC VARIATION; GENOTYPE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SEPSIS; SURVIVAL ANALYSIS; VANCOMYCIN-RESISTANT ENTEROCOCCI; YOUNG ADULT;

EID: 85006823088     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2016.10.002     Document Type: Article

References (37)

1. 1 Top, J., Willems, R., Bonten, M., Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 52 (2008), 297–308.
2. 2 Coombs, G.W., Pearson, J.C., Daley, D.A., Le, T., Robinson, O.J., Gottlieb, T., et al. Molecular epidemiology of enterococcal bacteremia in Australia. J Clin Microbiol 52 (2014), 897–905.
3. 3 Kwon, J.C., Kim, S.H., Choi, J.K., Cho, S.Y., Park, Y.J., Park, S.H., et al. Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the Catholic Blood and Marrow Transplantation Center. Infect Chemother 45 (2013), 51–61.
4. 4 Deshpande, L.M., Fritsche, T.R., Moet, G.J., Biedenbach, D.J., Jones, R.N., Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 58 (2007), 163–170.
5. 5 Low, D.E., Keller, N., Barth, A., Jones, R.N., Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32 (2001), S133–45.
6. 6 Hidron, A.I., Edwards, J.R., Patel, J., Horan, T.C., Sievert, D.M., Pollock, D.A., et al. National Healthcare Safety Network Team. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29 (2008), 996–1011.
7. 7 Bhalla, A., Pultz, N.J., Ray, A.J., Hoyen, C.K., Eckstein, E.C., Donskey, C.J., Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, Gram-negative bacilli and Vancomycin-resistant enterococci in the stool of colonized patients. Infect Control Hosp Epidemiol 24 (2003), 644–649.
8. 8 Zwielehner, J., Lassl, C., Hippe, B., Pointner, A., Switzeny, O.J., Remely, M., et al. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS ONE, 6, 2011, 10.1371/journal.pone.0028654 e28654.
9. 9 Giridhara Upadhyaya, P.M., Ravikumar, K.L., Umapathy, B.L., Review of virulence factors of Enterococcus: an emerging nosocomial pathogen. Indian J Med Microbiol 27 (2009), 301–305.
10. 10 Woodford, N., Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. Microb Drug Resist 7 (2001), 229–236.
11. 11 Cuellar-Rodríguez, J., Galindo-Fraga, A., Guevara, V., Pérez-Jiménez, C., Espinosa-Aguilar, L., Rolón, A.L., et al. Vancomycin-resistant enterococci, Mexico City. Emerg Infect Dis 13 (2007), 798–799.
12. 12 King, G., Gakidou, E., Imai, K., Lakin, J., Moore, R.T., Nall, C., et al. Public policy for the poor? A randomised assessment of the Mexican universal health insurance programme. Lancet 373 (2009), 1447–1454.
13. 13 Blot, F., Nitenberg, G., Brun-Buisson, C., New tools in diagnosing catheter-related infections. Support Care Cancer 8 (2000), 87–92.
14. 14 See, I., Iwamoto, M., Allen-Bridson, K., Horan, T., Magill, S.S., Thompson, N.D., Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infect Control Hosp Epidemiol 34 (2013), 769–776.
15. 15 Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. CLSI document M100-S23.
16. 16 Tenover, F.C., Swenson, J.M., O'Hara, C.M., Stocker, S.A., Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J Clin Microbiol 33 (1995), 1524–1527.
17. 17 Dutka-Malen, S., Evers, S., Courvalin, P., Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol, 33, 1995, 1434.
18. 18 Saeedi, K.B., Hallgren, A., Jonasson, J., Nilsson, L.T., Hanberger, H., Isaksson, B., Modified pulsed-field gel electrophoresis protocol for typing of enterococci. APMIS 110 (2002), 869–874.
19. 19 Castillo-Rojas, G., Mazari-Hiriart, M., Ponce de León, S., Amieva-Fernández, R.I., Agis-Juárez, R.A., López-Vidal, Y., Comparison of Enterococcus faecium and Enterococcus faecalis strains isolated from water and clinical samples: antimicrobial susceptibility and genetic relationships. PLoS ONE, 8, 2013 e59491.
20. 20 Tenover, F.C., Arbeit, R.D., Goering, R.V., Mickelsen, P.A., Murray, B.E., Persing, D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995), 2233–2239.
21. 21 Barbuddhe, S.B., Maier, T., Schwarz, G., Kostrzewa, M., Hof, H., Domann, E., et al. Rapid identification and typing of Listeria species by matrix-assisted laser desorption ionization–time of flight mass spectrometry. Appl Environ Microbiol 74 (2008), 5402–5407.
22. 22 Talebi, M., Rahimi, F., Katouli, M., Möllby, R., Pourshafie, M.R., Epidemiological link between wastewater and human vancomycin-resistant Enterococcus faecium isolates. Curr Microbiol 56 (2008), 468–473.
23. 23 Sneath, P., Sokal, R., Numerical taxonomy. The principle and practice of numerical classification. 1973, W. H. Freeman & Co, Ltd., San Francisco (CA).
24. 24 Kantarjian, H., Thomas, D., O'Brien, S., Cortes, J., Giles, F., Jeha, S., et al. Long-term follow-up results of hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 101 (2004), 2788–2801.
25. 25 Virchis, A., Koh, M., Rankin, P., Mehta, A., Potter, M., Hoffbrand, A.V., et al. Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without Idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. Br J Haematol 124 (2004), 26–32.
26. 26 Husni, R., Hachem, R., Hanna, H., Raad, I., Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol 23 (2002), 102–103.
27. 27 Zaas, A.K., Song, X., Tucker, P., Perl, T.M., Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 35 (2002), 1139–1146.
28. 28 Cobertura del Seguro Popular. Available from: http://www.seguro-popular.gob.mx/index.php/servicios/sistema-de-gestion-de-gastos-catastroficos Accessed October 30, 2016.
29. 29 Hawkins, C.A., Collignon, P., Adams, D.N., Bowden, F.J., Cook, M.C., Profound lymphopenia and bacteraemia. Intern Med J 36 (2006), 385–388.
30. 30 Bonten, M.J., Hayden, M.K., Nathan, C., van Voorhis, J., Matushek, M., Slaughter, S., et al. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet 348 (1996), 1615–1619.
31. 31 Weinstein, J.W., Roe, M., Towns, M., Sanders, L., Thorpe, J.J., Corey, G.R., et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol 17 (1996), 36–41.
32. 32 Carmeli, Y., Eliopoulos, G.M., Samore, M.H., Antecedent treatment with different antibiotics as a risk for vancomycin resistant enterococcus. Emerg Infect Dis 8 (2002), 802–807.
33. 33 Craig, M., Cumpston, A.D., Hobbs, G.R., Devetten, M.P., Sarwari, A.R., Ericson, S.G., The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. Bone Marrow Transplant 39 (2007), 477–482.
34. 34 Vergis, E.N., Hayden, M.K., Chow, J.W., Snydman, D.R., Zervos, M.J., Linden, P.K., et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med 135 (2001), 484–492.
35. 35 Stosor, V., Peterson, L.R., Postelnick, M., Enterococcus faecium Bacteremia. Does Vancomycin resistance make a difference?. Arch Intern Med 158 (1998), 522–527.
36. 36 Tomita, H., Tanimoto, K., Hayakawa, S., Morinaga, K., Ezaki, K., Oshima, H., et al. Highly conjugative pMG1-like plasmids carrying Tn1546-like transposons that encode vancomycin resistance in Enterococcus faecium. J Bacteriol 185 (2003), 7024–7028.
37. 37 Gardete, S., Tomasz, A., Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest 124 (2014), 2836–2840.